Related Experiment Video
Updated: May 27, 2026

Growth Assays to Assess Polyglutamine Toxicity in Yeast
Published on: March 5, 2012
Cell-autonomous and non-cell-autonomous toxicity in polyglutamine diseases
Fabio Sambataro1, Maria Pennuto
1Department of Neuroscience and Brain Technologies, Istituto Italiano di Tecnologia, Genova 16163, Italy.
Polyglutamine diseases involve neurodegeneration. New research shows these disorders are not just cell-autonomous, but also influenced by non-neuronal cells, impacting disease mechanisms.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Polyglutamine diseases are neurodegenerative disorders linked to expanded polyglutamine tracts in specific genes.
- Selective neuronal degeneration occurs despite widespread protein expression, suggesting cell-autonomous mechanisms.
- Previous understanding viewed these diseases as cell-autonomous, focusing on intrinsic neuronal damage.
Purpose of the Study:
- To describe cell-autonomous and non-cell-autonomous mechanisms in polyglutamine disease pathogenesis.
- To explore the role of non-neuronal cells in selective neuronal damage.
- To update the understanding of polyglutamine disease mechanisms.
Main Methods:
- Review of cell-autonomous and non-cell-autonomous mechanisms.
- Analysis of polyglutamine protein expression and toxicity.
- Examination of animal models with conditional polyglutamine protein expression.
Main Results:
- Polyglutamine diseases are not solely cell-autonomous.
- Toxicity in neighboring non-neuronal cells contributes significantly to neuronal damage.
- Mechanisms involve various cell types including neurons, skeletal muscle, glia, and germinal cells.
Conclusions:
- Polyglutamine disease pathogenesis involves both cell-autonomous and non-cell-autonomous pathways.
- Non-neuronal cell toxicity is a critical factor in selective neurodegeneration.
- A revised view of polyglutamine diseases incorporates broader cellular interactions.
Related Concept Videos
Drug Toxicity: Dose-Dependent Reactions
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Drug toxicity: Idiosyncratic Reactions
Parkinson Disease ll: Pathophysiology

